PHARMACYTE BIOTECH, INC. Accrued Liabilities, Current
PHARMACYTE BIOTECH, INC. (PMCB) had Accrued Liabilities, Current of $345.66 thousand as of 2026-07-31, per its 10-Q filed 2026-09-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-09-14
- 2026-07-31: Accrued Liabilities, Current $345.66K.
- 2026-04-30: Accrued Liabilities, Current $522.83K.
- 2026-01-31: Accrued Liabilities, Current $445.66K.
- 2025-10-31: Accrued Liabilities, Current $520.66K.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2026-07-31 | $345.66K 10-Q · filed 2026-09-14 | |
| 2026-04-30 | $522.83K 10-Q · filed 2026-09-14 | |
| 2026-01-31 | $445.66K 10-Q · filed 2026-03-17 | |
| 2025-10-31 | $520.66K 10-Q · filed 2025-12-18 | |
| 2025-07-31 | $595.66K 10-Q · filed 2025-09-15 | |
| 2025-04-30 | $2.52M 10-K · filed 2026-07-29 | |
| 2025-01-31 | $709.44K 10-Q · filed 2025-03-17 | |
| 2024-10-31 | $707.18K 10-Q · filed 2024-12-13 | |
| 2024-07-31 | $684.14K 10-Q · filed 2024-09-17 | |
| 2024-04-30 | $735.20K 10-K · filed 2025-08-11 | |
| 2024-01-31 | $774.44K 10-Q · filed 2024-03-18 | |
| 2023-10-31 | $1.02M 10-Q · filed 2023-12-15 | |
| 2023-07-31 | $480.04K 10-Q · filed 2023-09-18 | |
| 2023-04-30 | $458.30K 10-K · filed 2024-08-13 | |
| 2023-01-31 | $381.90K 10-Q · filed 2023-03-16 | |
| 2022-10-31 | $449.86K 10-Q · filed 2022-12-14 | |
| 2022-07-31 | $530.33K 10-Q · filed 2022-09-14 | |
| 2022-04-30 | $499.01K 10-K · filed 2023-07-31 | |
| 2022-01-31 | $520.12K 10-Q · filed 2022-03-15 | |
| 2021-10-31 | $29.08K 10-Q · filed 2021-12-14 | |
| 2021-07-31 | $530.20K 10-Q · filed 2021-09-14 | |
| 2021-04-30 | $552.52K 10-K · filed 2022-07-28 | |
| 2021-01-31 | $494.34K 10-Q · filed 2021-03-12 | |
| 2020-10-31 | $509.42K 10-Q · filed 2020-12-11 | |
| 2020-07-31 | $726.82K 10-Q · filed 2020-09-11 | |
| 2020-04-30 | $816.64K 10-K · filed 2021-08-10 | |
| 2020-01-31 | $678.36K 10-Q · filed 2020-03-13 | |
| 2019-10-31 | $639.27K 10-Q · filed 2019-12-23 | |
| 2019-07-31 | $539.01K 10-Q · filed 2019-09-13 | |
| 2019-04-30 | $620.97K 10-K · filed 2020-08-13 | |
| 2019-01-31 | $337.57K 10-Q · filed 2019-03-14 | |
| 2018-10-31 | $313.73K 10-Q · filed 2018-12-14 | |
| 2018-07-31 | $307.93K 10-Q · filed 2018-09-12 | |
| 2018-04-30 | $291.55K 10-K · filed 2019-08-13 | |
| 2018-01-31 | $281.56K 10-Q · filed 2018-03-19 | |
| 2017-10-31 | $256.15K 10-Q · filed 2017-12-14 | |
| 2017-07-31 | $237.50K 10-Q · filed 2017-09-13 | |
| 2017-04-30 | $214.65K 10-K · filed 2018-07-20 | |
| 2017-01-31 | $143.27K 10-Q · filed 2017-03-13 | |
| 2016-10-31 | $148.09K 10-Q · filed 2016-12-02 | |
| 2016-07-31 | $144.83K 10-Q · filed 2016-09-06 | |
| 2016-04-30 | $151.63K 10-K · filed 2017-07-27 | |
| 2016-01-31 | $68.12K 10-Q · filed 2016-03-08 | |
| 2015-10-31 | $52.80K 10-Q/A · filed 2016-01-19 | |
| 2015-07-31 | $43.32K 10-Q/A · filed 2016-01-19 | |
| 2015-04-30 | $23.67K 10-K · filed 2016-07-29 | |
| 2015-01-31 | $2.72K 10-Q · filed 2015-03-13 | |
| 2014-10-31 | $4.75K 10-Q · filed 2014-12-15 | |
| 2014-07-31 | $5.26K 10-Q · filed 2014-09-15 | |
| 2014-04-30 | $41.76K 10-K/A · filed 2016-01-19 | $7.80K 10-K · filed 2014-08-04 |
| 2014-01-31 | $51.77K 10-Q · filed 2014-03-17 | |
| 2013-10-31 | $48.45K 10-Q · filed 2013-12-16 | |
| 2013-07-31 | $23.65K 10-Q · filed 2013-09-16 | |
| 2013-04-30 | $12.30K 10-K · filed 2014-08-04 | |
| 2013-01-31 | $11.90K 10-Q · filed 2013-03-26 | |
| 2012-10-31 | $11.50K 10-Q · filed 2012-12-26 | |
| 2012-07-31 | $41.10K 10-Q · filed 2012-09-19 | |
| 2012-04-30 | $407.46K 10-K · filed 2013-07-29 | |
| 2012-01-31 | $356.25K 10-Q · filed 2012-03-21 | |
| 2011-10-31 | $346.38K 10-Q · filed 2011-12-15 | |
| 2011-07-31 | $310.26K 10-Q/A · filed 2011-09-20 | |
| 2011-04-30 | $274.14K 10-K · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |